发明名称 ISOINDOLE-IMIDE COMPOUNDS, COMPOSITIONS, AND USES THEREOF
摘要 The invention relates to isoindole-imide compounds and pharmaceutically acceptable salts, hydrates, solvates, clathrates, enantiomers, diastereomers, racemates, or mixtures of stereoisomers thereof, pharmaceutical compositions comprising these isoindole-imide compounds, and methods for reducing the level of cytokines and their precursors in mammals. In particular, the invention pertains to isoindole-imide compounds that are potents inhibitors of the production of the TNF- alpha in mammals. The isoindole-imides described herein are useful for treating or preventing diseases or disorders in mammals, for example, cancers, such as solid tumors and blood-born tumors; heart disease, such as congestive heart failure; osteoporosis; and genetic, inflammatory, allergic; and autoimmune diseases.
申请公布号 WO02059106(A1) 申请公布日期 2002.08.01
申请号 WO2001US50401 申请日期 2001.12.21
申请人 CELGENE CORPORATION;ROBARGE, MICHAEL, J.;CHEN, ROGER, SHEN-CHU;MULLER, GEORGE, W.;MAN, HON-WAH 发明人 ROBARGE, MICHAEL, J.;CHEN, ROGER, SHEN-CHU;MULLER, GEORGE, W.;MAN, HON-WAH
分类号 C07D401/02;A61K31/44;A61K31/454;A61P1/04;A61P9/00;A61P9/10;A61P11/00;A61P17/06;A61P19/02;A61P29/00;A61P35/00;A61P37/00;A61P43/00;C07D401/04;C07D401/14;C07D405/14;C07D409/14;(IPC1-7):C07D401/04;C07D407/14;A61K31/445;A61K31/495 主分类号 C07D401/02
代理机构 代理人
主权项
地址